SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001232524-19-000044
Filing Date
2019-08-06
Accepted
2019-08-06 17:11:18
Documents
97
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q jazz2019q2doc.htm   iXBRL 10-Q 2391536
2 OFFER LETTER jazzq22019ex104offeriannone.htm EX-10.4 23891
3 LETTER AGREEMENT jazzq22019ex105lettera.htm EX-10.5 12065
4 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq22019ex311.htm EX-31.1 12350
5 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq22019ex312.htm EX-31.2 12134
6 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 jazzq22019ex321.htm EX-32.1 8047
  Complete submission text file 0001232524-19-000044.txt   10191762

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20190630.xsd EX-101.SCH 58276
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jazz-20190630_cal.xml EX-101.CAL 135023
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jazz-20190630_def.xml EX-101.DEF 313724
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20190630_lab.xml EX-101.LAB 791987
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20190630_pre.xml EX-101.PRE 492025
12 EXTRACTED XBRL INSTANCE DOCUMENT jazz2019q2doc_htm.xml XML 1917729
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 191003047
SIC: 2834 Pharmaceutical Preparations